Drug Type Personalized antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms iNeo Vac P01, Neoantigen peptides vaccine, 肿瘤新生抗原多肽治疗性疫苗 + [3] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Hepatocellular Carcinoma | Phase 2 | China | 01 Aug 2025 | |
| Bile Duct Neoplasms | Phase 1 | China | 23 Jan 2024 | |
| Intestinal Neoplasms | Phase 1 | China | 23 Jan 2024 | |
| Melanoma | Phase 1 | China | 23 Jan 2024 | |
| Stomach Cancer | Phase 1 | China | 23 Jan 2024 | |
| Esophageal Carcinoma | Phase 1 | China | 02 Dec 2021 | |
| Non-Small Cell Lung Cancer | Phase 1 | China | 30 Oct 2020 | |
| Stage III Colon Cancer | Phase 1 | China | 30 Oct 2020 | |
| Advanced cancer | Phase 1 | China | 07 Feb 2018 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 07 Feb 2018 |
Phase 1 | Pancreatic Cancer Adjuvant | 9 | wlsvducoba(kaozuosden) = eefgvrcnqg lblwnvoadb (mgqbpojnxq ) View more | Positive | 05 Nov 2025 | ||
NCT03662815 (ASCO2022) Manual | Phase 1 | 28 | GM-CSF+iNeo-Vac-P01 (had received RFA treatment within 6 months before scheduled for vaccination) | lsansuznxa(utzuiihazs) = lyajexvksl jnktcraaiw (twtsstwhai ) View more | Positive | 02 Jun 2022 | |
GM-CSF+iNeo-Vac-P01 (had not received RFA treatment within 6 months before scheduled for vaccination) | lsansuznxa(utzuiihazs) = rqxodyvsdw jnktcraaiw (twtsstwhai ) View more | ||||||
Phase 1 | 7 | azoginttat(yoxmptcnfm) = nprshnrobi mrlrhuuymr (cswxghmyto ) View more | Positive | 13 Aug 2021 | |||
Phase 1 | 22 | czggjbsavg(topnokcfzd) = jhiqausexo mrgbepymod (jhapnbnoxo ) View more | Positive | 01 Sep 2020 | |||
Phase 1 | Biliary Tract Neoplasms neoantigens | 22 | personalized neoantigen peptide vaccine (iNeo-Vac-P01) | ummrwflrcw(pcjsmtdkni) = nausea, vomiting and rash lgzllebabx (bzgarixkdm ) View more | Positive | 01 Nov 2019 | |
PD-1 antibody |





